Search

Displaying results 8141 - 8150 of 10000 in total
  1. Drug

    Atevirdine

    go.drugbank.com/drugs/DB12264
    Investigational

    Atevirdine has been used in trials studying the treatment of HIV Infections.

  2. Drug

    Carisbamate

    go.drugbank.com/drugs/DB12338
    Investigational

    Carisbamate has been investigated in Alcohol Abuse, Substance Abuse, and Alcohol Dependence.

  3. Drug

    Rostafuroxin

    go.drugbank.com/drugs/DB12350
    Investigational

    Rostafuroxin has been used in trials studying the treatment of Essential Hypertension.

  4. Drug

    Razupenem

    go.drugbank.com/drugs/DB12587
    Investigational

    Razupenem has been used in trials studying the treatment of Skin Infections.

  5. Drug

    PF-477736

    go.drugbank.com/drugs/DB12611
    Investigational

    PF-00477736 has been used in trials studying the treatment of Neoplasms.

  6. Drug

    CE-326597

    go.drugbank.com/drugs/DB12694
    Investigational

    CE-326,597 has been used in trials studying the treatment of Obesity.

  7. Drug

    Acediasulfone

    go.drugbank.com/drugs/DB08926
    Experimental

    Acediasulfone (INN) is an antimicrobial and antimalarial long-acting prodrug of dapsone.

  8. Drug

    Defoslimod

    go.drugbank.com/drugs/DB20763
    Investigational

    Defoslimod is under investigation in clinical trial NCT01800812 (Effects of OM-174 in Adult Patients With Solid Tumors). Defoslimod has a monoisotopic molecular weight of 1148.65 Da. … The usage of the INN stem '-imod' in the name indicates that Defoslimod is a immunomodulator, both stimulant/suppressive and stimulant.

  9. Drug

    Empesertib

    go.drugbank.com/drugs/DB19473
    Investigational

    Empesertib is under investigation in clinical trial NCT02138812 (Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel). … The usage of the INN stem '-sertib' in the name indicates that Empesertib is a serine/threonine kinase inhibitor.

  10. Drug

    Ancremonam

    go.drugbank.com/drugs/DB19710
    Investigational

    Ancremonam is under investigation in clinical trial NCT03377426 (LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)). … The usage of the INN stem '-monam' in the name indicates that Ancremonam is a monobactam antibiotic.